Systemic sclerosis, also known as scleroderma, is a rare and complex autoimmune
connective-tissue disease. Once considered an untreatable and unpredictable condition …

Systemic sclerosis is a rare and chronic connective tissue disease with a multifaceted
pathogenesis characterised by heterogeneous multi-organ clinical manifestations. Every …

Objective This phase 3 study was undertaken to investigate the efficacy and safety of
lenabasum, a cannabinoid type 2 receptor agonist, in patients with diffuse cutaneous …

Systemic sclerosis (SSc) is a connective tissue disease characterised by diffuse
microangiopathy and immune dysregulation which ultimately results in widespread fibrosis …

Background The economic burden of interstitial lung disease (ILD) is unknown, limiting
informed resource allocation and planning. We sought to conduct the first systematic review …

Background As Systemic Sclerosis (SSc) is a connective tissue ailment that impacts various
bodily systems. The study aims to clarify the molecular subtypes of SSc, with the ultimate …

Background and objective The study aimed to evaluate the direct and indirect costs of
systemic sclerosis (SSc) in cases with and without interstitial lung disease (ILD). Methods …

Objectives The aim of this study was to identify risk factors associated with mortality in
patients with systemic sclerosis (SSc), particularly those with interstitial lung disease (ILD) …

Abstract Objective Systemic sclerosis (SSc) is characterized by vasculopathy, fibrosis of skin
and internal organs, and autoimmunity with complications including interstitial lung disease …

Objective To describe the frequency of progressive pulmonary fibrosis (PPF) in an incident
cohort of systemic sclerosis (SSc)-related interstitial lung disease (ILD) and its impact on …